{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5ef19dcae2ab35296efe4cc1/5f95a4631725ee6101cbba09?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"A paradigm shift in the diagnosis of prostate cancer","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5ef19dcae2ab35296efe4cc1/1603723697246-803c7f9cc28cbda0445ff75173ed19d4.jpeg?height=200","description":"<p>Inify,&nbsp;ContextVision’s&nbsp;first digital pathology product for diagnosis of prostate cancer using deep learning and artificial intelligence, is on track regarding commercialisation.</p>","author_name":"ContextVision"}